News
Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up ...
Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management ...
Health systems across the U.S. are increasingly launching or expanding their own health plans to enhance care coordination, improve patient outcomes and reduce costs. Becker’s has curated a list of ...
Yet the market treats it like a sluggish legacy player. At just 9x forward earnings and under 1x tangible book, Cigna screens ...
Revenue reached $67.2 billion, beating analyst estimates by 7.3% (non-GAAP) and growing 11% year over year. Adjusted earnings per share (EPS) rose to $7.20, surpassing expectations and EPS increased 7 ...
The Cigna Group (CI) reports robust financial performance with $67.2 billion in revenue, while navigating elevated medical costs and regulatory challenges.
In a report released today, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Cigna, with a price target of $365.00. The company’s shares closed yesterday at $297.86. Take advantage of ...
So far, even as high up as Santa’s Village in Jefferson, the poor air quality from Canadian wildfire smoke hasn’t stopped ...
Cambria County Commissioners are drafting a letter to urge a pharmacy benefit manager to reconsider its decision to terminate a contract with local pharmacies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results